medigraphic.com
Instituto Nacional de Salud Pública

2018, Number 1

<< Back Next >>

salud publica mex 2018; 60 (1)

The hidden burden of Chikungunya in central Mexico: results of a small-scale serosurvey

Cortes-Escamilla A, López-Gatell H, Sánchez-Alemán MÁ, Hegewisch-Taylor J, Hernández-Ávila M, Alpuche-Aranda CM

Language: English
References: 29
Page: 63-70
PDF size: 585.32 Kb.


ABSTRACT

Objective. To estimate the seroprevalence of CHKV antibodies and assess correlates of seropositivity at a small geographical scale. Materials and methods. A community- based serosurvey of 387 households in Puente de Ixtla, Morelos (central Mexico). Serum IgG antibodies to CHKV were detected by immunoassay. Results. From 27 April to 29 May 2016, we interviewed and collected blood samples from 387 individuals at the same number of households. A total of 114 (29.5%) participants were seropositive to CHK, 36 (31.6%) of them reported no symptoms of CHKV infection within 12 months before the survey. Conclusion. The estimated seroprevalence to CHKV antibodies was higher than expected by the small number of confirmed cases of CHKV infection reported in Mexico by the National Surveillance System.


REFERENCES

  1. Acosta-Reyes J, Navarro-Lechuga E, Martínez-Garcés JC. Chikungunya fever: history and epidemiology. Salud Uninorte. 2015;31(3):621-30. https://doi.org/10.14482/sun.31.3.7486

  2. Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya virus infection: an overview. New Microbiol. 2013;36(3):211-227.

  3. Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, et al. Chikungunya Virus in North-Eastern Italy: A Seroprevalence Survey. Am J Trop Med Hyg. 2010;82(3):508-11. https://doi.org/10.4269/ajtmh. 2010.09-0322

  4. Martínez-Fernández L, Torrado-Navarro YP. Fiebre Chikungunya. Rev Cubana Med. 2015;54:74-96 [cited 2016 oct 23]. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75232015000100008&nrm=iso

  5. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a reemerging virus. Lancet. 2012;379(9816):662-71. https://doi.org/10.1016/ S0140-6736(11)60281-X

  6. Rivera-Ávila RC. Fiebre chikungunya en México: caso confirmado y apuntes para la respuesta epidemiológica. Salud Publica Mex. 2014;56(4):402-4 [cited 2017 nov 23]. Available from: https: //www. saludpublica.mx/index.php/spm/article/view/7361

  7. Pan American Health Organization. Número de casos reportados de chikungunya en países o territorios de las Américas 2016 (por semanas)/ Semana Epidemiológica 17 (29 abril 2016). Washington: PAHO, 2016.

  8. Pan America Health Organization. Número de casos reportados de chikungunya en países o territorios de las Américas 2015 (por semanas)/ Semana Epidemiológica 52. Washington: PAHO, 2015.

  9. Pan American Health Organization. Número de casos reportados de chikungunya en países o territorios de las Américas 2013-2014 (por semanas)/Semana Epidemiológica 52. Washington: PAHO, 2014.

  10. Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7(5):319-27. https://doi. org/10.1016/S1473-3099(07)70107-X

  11. Gilotra SK, Rozeboom LE, Bhattacharya NC. Observations on possible competitive displacement between populations of Aedes aegypti Linnaeus and Aedes albopictus Skuse in Calcutta. Bull World Health Organ. 1967;37(3):437.

  12. Szyfres B, Acha PN. Zoonosis y enfermedades transmisibles comunes al hombre y a los animales: clamidiosis, rickettsiosis y virosis. 3.ed. Washington DC: Pan American Health Organization, 2003 [cited 2015, Oct 26]. Available from: http://www.who.int/iris/handle/10665/165501

  13. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Micro. 2010;8(7):491-500. https://doi.org/10.1038/nrmicro2368

  14. Ministerio de salud. Lineamientos para la Vigilancia Epidemiológica y Diagnóstico por Laboratorio de Fiebre Chikungunya. MINSA, 2014 Nov;(2):2-3 [cited 2015 Feb 9]. Available from: http://promocion.salud.gob. mx/archivos/Lineamientos_Chikungunya_25nov14.pdf

  15. Lo Presti A, Lai A, Cella E, Zehender G, Ciccozzi M. Chikungunya virus, epidemiology, clinics and phylogenesis: A review. Asian Pac J Trop Med. 2014;7(12):925-32. Available from: https://doi.org/10.1016/S1995- 7645(14)60164-4

  16. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010;104(6):392-9. https://doi.org/10.1016/j. trstmh.2010.01.011

  17. Tavárez-Villamán Y (coord). Guía de manejo clínico para la infección por el virus chikungunya (CHIKV). Santo Domingo: Ministerio de Salud Pública República Dominicana, 2014.

  18. Instituto Nacional de Estadística y Geografía. Mapa Digital de México, [Morelos-Puente de Ixtla]: INEGI, 2003 [cited 2016, Feb 18]. Available from: http://gaia.inegi.org.mx/mdm6/?v=bGF0OjE4LjYyMjM2LGxvbjotOT kuMzIxNjIsejoxNSxsOmMxMTFzZXJ2aWNpb3N8dGMxMTFzZXJ2aW Npb3M=

  19. Instituto Nacional para el Federalismo y el Desarrollo Municipal. Estado de Morelos. Puente de Ixtla: Inafed. 2015 [cited 2015, Sep 30]. Available from: http://www.inafed.gob.mx/work/enciclopedia/EMM17morelos/ municipios/17017a.html

  20. Drebot MA, Valadere AM, Goodman CH, Johnson BW, de Salazar PM, Holloway K. Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays. Am J Trop Med Hyg. 2016;95(1):182- 92. https://doi.org/10.4269/ajtmh.16-0013

  21. Rodríguez-Barraquer I, Solomon SS, Kuganantham P, Srikrishnan AK, Vasudevan CK, Iqbal SH, et al. The Hidden Burden of Dengue and Chikungunya in Chennai, India. PLoS Negl Trop Dis. 2015;9(7):e0003906. https:// doi.org/10.1371/journal.pntd.0003906

  22. Robinson M, Conan A, Duong V, Ly S, Ngan C, Buchy P, et al. A Model for a Chikungunya Outbreak in a Rural Cambodian Setting: Implications for Disease Control in Uninfected Areas. PLoS Negl Trop Dis. 2014;8(9):e3120. https://doi.org/10.1371%2Fjournal.pntd.0003120

  23. Sissoko D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet JL, et al. Seroprevalence and Risk Factors of Chikungunya Virus Infection in Mayotte, Indian Ocean, 2005-2006: A Population-Based Survey. PLoS One. 2008;3(8):e3066. https:// doi.org/10.1371/journal.pone.0003066

  24. Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, et al. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines. PLoS Negl Trop Dis. 2015;9(5):e0003764. https://doi.org/10.1371/journal. pntd.0003764

  25. Dantés HG, Farfán-Ale JA, Sarti E. Epidemiological Trends of Dengue Disease in Mexico (2000-2011): A Systematic Literature Search and Analysis. PLoS Negl Trop Dis. 2014;8(11):e3158. https://doi.org/10.1371/ journal.pntd.0003158

  26. Chien YW, Shu YC, Chuang KT, Yeh CY, Ko WC, Ko NY, et al. High estimated prevalence of asymptomatic dengue viremia in blood donors during a dengue epidemic in southern Taiwan, 2015. Transfusion. 2017;0:1- 8. https://doi.org/10.1111/trf.14281

  27. Atif M, Azeem M, Sarwar MR, Bashir A. Zika virus disease: a current review of the literature. Infection. 2016;44(6):695-705. https://doi. org/10.1007/s15010-016-0935-6

  28. Ramachandran V, Malaisamy M, Ponnaiah M, Kaliaperuaml K, Vadivoo S, Gupte MD. Impact of Chikungunya on Health Related Quality of Life Chennai, South India. PLoS One. 2012;7(12):e51519. https://doi. org/10.1371/journal.pone.0051519

  29. Mulligan K, Dixon J, Sinn C-LJ, Elliott SJ. Is dengue a disease of poverty? A systematic review. Pathog Glob Health. 2015;109(1):10-8. https://doi.org /10.1179/2047773214Y.0000000168




2020     |     www.medigraphic.com